NEW YORK, NY -- (Marketwire) -- 01/29/13 -- Health Care stocks have been on an impressive run to start 2013. The Affordable Care Act will provide millions of Americans with access to healthcare, creating new revenue streams for companies across the sector. Research Driven Investing examines investing opportunities in the Health Care Sector and provides equity research on HCA Holdings Inc. (NYSE: HCA) and Tenet Healthcare Corporation (NYSE: THC).
The Affordable Care Act (Obamacare) requires every American to acquire health insurance by 2014 or be subjected to a tax. For those who can't afford health insurance they will be offered subsidies or Medicaid. Statistics from the Census Bureau show that approximately 50 million Americans did not have health insurance in 2009.
According to the Centers for Medicare and Medicaid Services total health care spending is projected to grow from an estimated $2.8 trillion last year to $4.8 trillion by 2021, an increase of 70 percent. "There's just a lot more money flowing into health care and we're seeing the markets react accordingly," says Invesco portfolio manager, Derek Taner.
Research Driven Investing releases regular market updates on the Health Care Sector so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and industry newsletters.
HCA owns and operates approximately 163 hospitals and approximately 109 freestanding surgery centers in 20 states and London, England. The company is scheduled to release its fourth quarter 2012 and full year results on Monday, February 4th. Shares of HCA have 25 percent year-to-date.
Tenet Healthcare through its subsidiaries operates 49 hospitals, over 100 free-standing outpatient centers and Conifer Health Solutions, a leader in business process solutions for health care providers serving more than 500 hospital and health care entities nationwide. The company reported a net income of $40 in the third quarter of 2012, compared to a net income of $6 million in the third quarter of 2011.
Research Driven Investing has not been compensated by any of the above-mentioned publicly traded companies. Paragon Report is compensated by other third party organizations for advertising services. We act as an independent research portal and are aware that all investment entails inherent risks. Please view the full disclaimer at: